{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Corona",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "62383",
      "recalling_firm": "Watson Laboratories Inc",
      "address_1": "311 Bonnie Cir",
      "address_2": "N/A",
      "postal_code": "92880-2882",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-1399-2012",
      "product_description": "Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880  NDC #  00591-0369-01.",
      "product_quantity": "8254 bottles",
      "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.",
      "recall_initiation_date": "20120417",
      "center_classification_date": "20120629",
      "termination_date": "20130318",
      "report_date": "20120711",
      "code_info": "Lot 108094A"
    }
  ]
}